148 related articles for article (PubMed ID: 36516005)
1. Up-Front Versus Delayed Thermal Ablation for Colorectal Liver Oligometastases: A Multicenter Retrospective Study Using Propensity Score Matching.
Li J; Yu J; Liu G; Xie X; Zhang DZ; Zheng R; Yang H; Zhong H; Lu S; Xiang H; Cai X; Dai G; Luo Y; Liang P
AJR Am J Roentgenol; 2023 Jun; 220(6):885-899. PubMed ID: 36516005
[No Abstract] [Full Text] [Related]
2. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
[TBL] [Abstract][Full Text] [Related]
3. Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
Li J; Liu G; Xie X; Zhang D; Zheng R; Yang H; Zhong H; Dai G; Yu J; Liang P
Radiology; 2023 Aug; 308(2):e223135. PubMed ID: 37581502
[TBL] [Abstract][Full Text] [Related]
4. Resection vs. ablation for lesions characterized as resectable-ablative within the colorectal liver oligometastases criteria: a propensity score matching from retrospective study.
Luo M; Chen SL; Chen J; Yan H; Qiu Z; Chen G; Lu L; Zhang F
PeerJ; 2020; 8():e8398. PubMed ID: 32025372
[TBL] [Abstract][Full Text] [Related]
5. Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study.
Xu Y; Zhang Y; Zheng CZ; Li C; Guo T; Xu Y
Eur Radiol; 2022 Oct; 32(10):6678-6690. PubMed ID: 35999370
[TBL] [Abstract][Full Text] [Related]
6. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Clinical Efficacy of Thermal Ablation vs. Surgical Resection of Metachronous Colorectal Liver Metastasis].
Yao ZH; Zhang K; Luo YG; Li YJ; Yang C; Yang HC; Cong TH; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):481-487. PubMed ID: 35642158
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
9. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
[TBL] [Abstract][Full Text] [Related]
11. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
[TBL] [Abstract][Full Text] [Related]
12. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K
AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517
[No Abstract] [Full Text] [Related]
13. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
14. Trends and overall survival after combined liver resection and thermal ablation of colorectal liver metastases: a nationwide population-based propensity score-matched study.
de Graaff MR; Klaase JM; den Dulk M; Coolsen MME; Kuhlmann KFD; Verhoef C; Hartgrink HH; Derksen WJM; van den Boezem P; Rijken AM; Gobardhan P; Liem MSL; Leclercq WKG; Marsman HA; van Duijvendijk P; Bosscha K; Elfrink AKE; Manusama ER; Belt EJT; Doornebosch PG; Oosterling SJ; Ruiter SJS; Grünhagen DJ; Burgmans M; Meijerink M; Kok NFM; Swijnenburg RJ;
HPB (Oxford); 2024 Jan; 26(1):34-43. PubMed ID: 37777384
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation.
Zhou Q; An Y; Liu T; Liu Z; Li R; Wang C; Zhou F; Liu C; Zhu K
Int J Hyperthermia; 2022; 39(1):97-107. PubMed ID: 34979845
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
20. Microwave ablation versus resection for colorectal cancer liver metastases - A propensity score analysis from a population-based nationwide registry.
Tinguely P; Dal G; Bottai M; Nilsson H; Freedman J; Engstrand J
Eur J Surg Oncol; 2020 Mar; 46(3):476-485. PubMed ID: 31837931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
